Skip to main content

Advertisement

Table 2 Therapeutic response at day 28, after PCR adjustment, in vivo study, Dabola

From: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

Results AS/AQ (n = 102) AS/SP (n = 99)
  N % 95%CI N % 95%CI
Early Treatment failure 0 0 0–3.5 1 1 0–5.5
Late Treatment Failure 1 1.0 0–3.5 0 0 0–3.7
Total failure 1 1.0 0–5.3 1 1.0 0–5.5
ACPR 101 99.0 94.7–99.8 98 99.0 94.5–99.8
  1. Outcome classification according to WHO guidelines [4]
  2. Late Treatment Failure = Late Clinical Failure + Late Parasitological Failure
  3. ACPR: Adequate Clinical and Parasitological Response
  4. Outcome classification is WHO (2003)